Prostate cancer (PCa) is a tumor with a great heterogeneity, both at a molecular and clinical
level. Despite its global good prognosis, cases can vary from indolent to lethal metastatic …

Abstract Background Compound Kushen Injection (CKI) is a Chinese patent drug that exerts
curative effects in the clinical treatment of hepatocellular carcinoma (HCC). This study aimed …

Introduction We describe the development of a molecular assay from publicly available
tumor tissue mRNA databases using machine learning and present preliminary evidence of …

The expression of matrix-metalloproteinase-2 in bone marrow micro-metastasis is associated
with the presence of circulating prostate cells and a worse prognosis in men treated with radical …

Background Some patients with prostate cancer (PCa) will experience biochemical
recurrence (BCR) after treatment. Current researches have identified the influencing factors …

Background: Head and neck squamous cell carcinoma (HNSCC) is one of the most common
malignant tumors. The purpose of this study was to establish and validate a gene …

Simple Summary Around 30% of patients with oligometastatic prostate cancer relapse will
benefit from local PET/CT-guided ablative radiotherapy (RT) with improved progression-free …

Objective The objective of this study was to compare the CAPRA-S score (based on
clinicopathological findings) and the subtypes of minimal residual disease (MRD)(based on …

Results 309 men participated with a median follow-up of 8 years. The risk of biochemical
failure increased proportionally with increasing CAPRA score, hazard ratio 1.18 for …

Funktionelle Untersuchungen zur Rolle von Polyphosphat-bindenden Proteinen bei der
Immunantwort Dissertation zur Erlangung des Page 1 Funktionelle Untersuchungen zur Rolle …